BioNTech SE BNTX has filed a patent infringement lawsuit against Moderna Inc. MRNA, alleging that Moderna's next-generation ...
Arbutus alleges that Moderna’s COVID-19 vaccine infringes on patents protecting its lipid nanoparticle delivery technology.
Morning Overview on MSN
FDA agrees to evaluate Moderna mRNA flu vaccine after initial refusal
The U.S. Food and Drug Administration has agreed to evaluate Moderna’s investigational mRNA-based seasonal influenza vaccine, mRNA-1010, reversing a refusal-to-file decision it issued just weeks ...
Add Yahoo as a preferred source to see more of our stories on Google. Moderna's headquarters in Cambridge, Mass., in 2024. (Adam Glanzman / Bloomberg via Getty Images) (Adam Glanzman) The Food and ...
The Food and Drug Administration has reversed course and agreed to review Moderna’s application for the first mRNA-based flu vaccine under a revised approach, company and federal officials said ...
(THE CONVERSATION) The Food and Drug Administration’s decision, made public on Feb. 10, 2026, to not review an application to approve Moderna’s proposed mRNA-based flu vaccine set off a firestorm of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results